Gilead Sciences reported additional data from the company’s Phase III SIMPLE-Severe trial and a real-world retrospective group of patients with severe COVID-19.
AstraZeneca’s cancer drug Calquence has shown initial signs of helping hospitalized COVID-19 patients get through the worst of the disease, as researchers scramble to repurpose existing treatments to help fight the deadly infection.
The U.S. National Institutes of Health (NIH) said data from the company’s trial of Gilead Sciences Inc.’s remdesivir show that the drug offers the most benefit for COVID-19 patients who need extra oxygen but do not require mechanical ventilation.
Hospitalizations of people with the novel coronavirus fell for a second day in New York and the state would send ventilators to Michigan and Maryland, further signs some control is being gained on the outbreak, Governor Andrew Cuomo said on Wednesday.
Ford Motor Co. will produce 50,000 ventilators over a 100-day period at a plant in Michigan in cooperation with General Electric’s healthcare unit, and can then build 30,000 per month as needed to treat patients afflicted with the coronavirus.